Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 6Observational 3

Sponsor

Cancer Type

Tumor-Agnostic 5Head & Neck 4Other hematologic neoplasm 3Gynecologic 3Dermatologic 3Breast 3Gastrointestinal 2Lymphoid 1

Conditions

Breast Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Breast Cancer Survivors 1

Interventions

Surveys and Questionnaires 79Blood Specimen Collection 67palbociclib 40Trastuzumab 34Drug Therapy 30Letrozole 29Anastrozole 27Radiotherapy 26Immunohistochemistry 26Mastectomy, Segmental 22Amplified Fragment Length Polymorphism Analysis 22Fulvestrant 21Biopsy 21exemestane 20Tamoxifen 20Interviews as Topic 20Gene Expression Profiling 20Magnetic Resonance Spectroscopy 19ribociclib 18Specimen Handling 18Mastectomy 18Neoadjuvant Therapy 17Paclitaxel 16High-Energy Shock Waves 16Capecitabine 16trastuzumab deruxtecan 15Mammography 15Psychiatric Rehabilitation 14Polymerase Chain Reaction 13Observation 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Restraint, Physical × Breast × Clear all
NCT06334354 2026-05-14

TRAC

Memorial Sloan Kettering Cancer Center

Recruiting
420 enrolled
Breast

Breast Cancer Survivors

NCT05178498 2025-02-06

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

Ohio State University Comprehensive Cancer Center

Recruiting
960 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01051609 2016-09-09

Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer Patients

Jonsson Comprehensive Cancer Center

Completed
27 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡